(MedPage Today) — SAN ANTONIO — Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune activation and tumor response in node-positive hormone receptor-positive (HR+)/HER2-negative breast cancer…
Webinar on allied health and nursing to be held on May 11
With the growing demand for quality healthcare services, allied health and nursing professionals are playing an increasingly significant role in...






